Search results for: 'shared services'
- Related search terms
- Services 2.0: The New Business Frontier for Profitability
- services+markets
- services 20 the new business frontier for profitability
- services market
- services economic implications in automotive industry
-
21 Mar 2025  |  Global  |  Market Research
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...
$4,950.00
Special Price $4,455.00 save 10 %
-
10 Sep 2024  |  Global  |  Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...
$4,950.00
Special Price $4,207.50 save 15 %
-
25 Apr 2024  |  Global  |  Frost Radar
Frost Radar™: Healthcare Enterprise Managed Cloud Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
In the cloud industry and most other technology-related industries, 2024 will be all about artificial intelligence (AI). Businesses are grappling with how they can leverage AI (particularly generative AI) to meet their goals. Public cloud providers are at the forefront of efforts to accelerate customers AI adoption by developing foundational model...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Feb 2022  |  Global  |  Frost Radar
Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Aug 2023  |  Global  |  Market Research
Global Outpatient Care Imaging Services Growth Opportunities
Value Delivery of Radiology Services Across Different Outpatient Care Settings will Influence the Medical Imaging Market
This study addresses the imaging services trends and challenges seen at various global outpatient imaging sites. The focus of this study addresses various imaging services provided using modalities such as fixed and portable X-ray and ultrasound devices as well as advanced imaging equipment such as mammography, CT, MRI, C-arm, and molecular imaging...
$2,450.00
Special Price $1,837.50 save 25 %
-
10 May 2024  |  Global  |  Market Research
Growth Opportunities in the Global Hospital-at-home Platforms and Services Industry, Forecast to 2029
In-hospital Care Challenges and Promising Hospital-at-home Outcomes Will Spur Future Growth Potential
The hospital-at-home (HaH) care model provides hospital-grade care in a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure. This analysis will cover market size and forecast at the solution level, including technological solutions and care coordination services for acute care management HaH...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...
$4,950.00
Special Price $4,207.50 save 15 %
-
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
24 Nov 2025  |  Global  |  Market Research
Building Digital Healthcare Ecosystems: The Future of Digital Health, 2040
From Episodic Visits to Continuous, Agent-orchestrated Care on Shared Trust/Data Rails
This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...
$2,450.00 -
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %